References

HIV transmission elimination
Public Health Scotland
  1. Palfreeman A, Sullivan A, Rayment M, Waters L, Buckley A, Burns F, et al. British HIV Association/British Association for Sexual Health and HIV/British Infection Association adult HIV testing guidelines 2020. HIV Med. 2020;21 Suppl 6:1-26.
  2. Damery S, Nichols L, Holder R, Ryan R, Wilson S, Warmington S, et al. Assessing the predictive value of HIV indicator c conditions in general practice: a case-control study using the THIN database. Br J Gen Pract. 2013;63(611):e370-7.
  3. Valbert F, Behrens GMN, Bickel M, Boesecke C, Esser S, Droge P, et al. Prevalence of HIV in people with potential HIV- i indicator conditions in Germany: an analysis of data from statutory health insurances. EClinicalMedicine. 2024;73:102694.
  4. Ammi Shah, Neil Mackay, Hannah Kitt, Catriona Harrison, Kedeen Okumu-Camerra, Natasha Ratna, Victoria Schoemig, Cuong Chau, Veronique Martin, Alison Brown, Tamara Đuretić. HIV testing, PrEP, new HIV diagnoses and care outcomes  for people accessing HIV services: 2025 report. The annual official statistics data release (data to end of December 2024).  October 2025, UK Health Security Agency, London 
  5. Hart E , Kitt H , Gilleece Y , Donohoe K , Shah A ,Martin V, Burns F, Djuretic T. Analysis of the very late HIV diagnosis review findings for 2024 and 2025. HIV Medicine: Volume 27, Issue S1; 6th Joint Conference of BHIVA with BASHH, 27 April – 29 April 2026, Liverpool, UK. Abstract 022.
  6. HIV testing: increasing uptake among people who may have undiagnosed HIV. Economic assessment: resource impact of National Institute for Health and Care Excellence; 2016.
  7. Haukoos J, Hopkins E, Campbell JD, Lyons MS, Rothman RE, Hsieh YH, et al. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial. Ann Emerg Med. 2024;84(3):234-43. 
  8. Baggaley RF, Irvine MA, Leber W, Cambiano V, Figueroa J, McMullen H, et al. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis. Lancet HIV. 2017;4(10):e465-e74.
  9. Lee YH, Bang JH, Park SM, Kang CR, Cho SI, Oh MD, et al. Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea. J Korean Med Sci. 2018;33(46):e304.
  10. Jordans CCE, Vliegenthart-Jongbloed K, Osbak KK, Hanssen JLJ, van Beek J, Vriesde M, et al. Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial. AIDS. 2025;39(8):995-1004. 
  11. Bulteel N, Henderson N, Parris V, Capstick R, Premchand N, Hunter E, et al. HIV testing in secondary care: a multicentre longitudinal mixed methods electronic survey of non-HIV specialist hospital physicians in South-East Scotland and Northern England. J R Coll Physicians Edinb. 2021;51(3):230-6. 
  12. Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadziosmanovic V, Vassilenko A, et al. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015. PLoS One. 2019;14(8):e0220108.
  13. Sogaard OS, Lohse N, Ostergaard L, Kronborg G, Roge B, Gerstoft J, et al. Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One. 2012;7(3):e32538.
  14. Hsu DT, Ruf M, O'Shea S, Costelloe S, Peck J, Tong CY. Diagnosing HIV infection in patients presenting with glandular fever-like illness in primary care: are we missing primary HIV infection? HIV Med. 2013;14(1):60-3.
  15. Joore IK, Arts DL, Kruijer MJ, Moll van Charante EP, Geerlings SE, Prins JM, et al. HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care. Sex Transm Infect. 2015;91(7):467-72. 
  16. Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition- guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845.
  17. Sharvill R, Fernandes A, Allen K, Astin J. Adopting universal testing for HIV in intensive care for patients admitted with severe pneumonia: results from our change in practice. Int J STD AIDS. 2017;28(1):88-90.
  18. Clifton DC, Clement ME, Holland TL, Cox GM, Dicks KV, Stout JE. Suboptimal HIV Testing Among Patients Admitted With Pneumonia: A Missed Opportunity. AIDS Educ Prev. 2017;29(4):377-88.
  19. Richardson D, Pakianathan M, Ewens M, Mitchell H, Mohammed H, Wiseman E, et al. British Association of Sexual Health and HIV (BASHH) United Kingdom national guideline for the management of sexually transmitted enteric infections 2023. Int J STD AIDS. 2023;34(9):588-602.